SCHEMBL3170630

SCHEMBL3170630

CC(=O)NCCNc1cc(NCCNC(=O)/C=C/c2ccccc2)nc(-c2ccc(Cl)cc2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.49
MEN1 O00255 3/20 0.49
MAPT P10636 3/20 0.49
NLRP3 Q96P20 1/20 0.49
PIM2 Q9P1W9 1/20 0.48
CYP1A2 P05177 3/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
ALDH1A1 P00352 3/20 0.44
HPGD P15428 1/20 0.44
EGFR P00533 2/20 0.43
ADORA3 P0DMS8 1/20 0.43
MMP1 P03956 2/20 0.43
MMP2 P08253 2/20 0.43
MMP9 P14780 2/20 0.43
RECQL P46063 2/20 0.43
POLB P06746 1/20 0.43
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3170642 1.00 KMT2A (0.49) KMT2AMEN1MAPTNLRP3PIM2
SCHEMBL3163623 0.93 PIM2 (0.44) KMT2AMEN1MAPTNLRP3PIM2
SCHEMBL3163636 0.93 PIM2 (0.44) KMT2AMEN1MAPTNLRP3PIM2
SCHEMBL3171042 0.93 PIM2 (0.54) KMT2AMAPTPIM2CYP1A2ALDH1A1
SCHEMBL3171072 0.93 PIM2 (0.54) KMT2AMAPTPIM2CYP1A2ALDH1A1
SCHEMBL3163340 0.89 SMN1; SMN2 (0.51) KMT2AMEN1MAPTNLRP3PIM2
SCHEMBL3163351 0.89 SMN1; SMN2 (0.51) KMT2AMEN1MAPTNLRP3PIM2
SCHEMBL3164980 0.87 CYP1A2 (0.43) MAPTNLRP3PIM2CYP1A2CYP2C19
SCHEMBL3164995 0.87 CYP1A2 (0.43) MAPTNLRP3PIM2CYP1A2CYP2C19
SCHEMBL3169453 0.87 CYP1A2 (0.47) KMT2AMEN1MAPTPIM2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed